VivaLNK has announced the availability of a wearable ECG monitoring solution designed to wirelessly capture ECG and heart rate during a six-minute walk test (6MWT).
The VivaLNK solution is used for clinical research in a variety of applications, such as cardiac rehab, digital biomarkers of arrhythmia onset, and pharmaceutical clinical trials, and includes a wearable ECG patch, a specialized mobile app, and cloud data services. In these studies, patients wear the wireless ECG patch while a clinician is able to monitor and control the test using a mobile app. Data collected during the test is then consolidated into a centralized database in the cloud for post analysis.
For more information, click here.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Putting Collective Insights Into Action to Advance Cancer Care: Key Examples From ASCO 2025
June 27th 2025At ASCO 2025, clinical operations leaders gained critical insights into how AI tools, bispecific antibodies, and evolving treatment paradigms are reshaping trial design, endpoint selection, and patient stratification.